Found: 11
Select item for more details and to access through your institution.
A Methodological Quality Assessment of Meta-Analysis Studies in Dance Therapy Using AMSTAR and AMSTAR 2.
- Published in:
- Healthcare (2227-9032), 2020, v. 8, n. 4, p. 446, doi. 10.3390/healthcare8040446
- By:
- Publication type:
- Article
Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4839, doi. 10.3390/cancers14194839
- By:
- Publication type:
- Article
Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143440
- By:
- Publication type:
- Article
Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5835, doi. 10.3390/cancers13225835
- By:
- Publication type:
- Article
HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.834104
- By:
- Publication type:
- Article
The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.792340
- By:
- Publication type:
- Article
Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in Korea.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 2, p. 225, doi. 10.1007/s12185-022-03479-6
- By:
- Publication type:
- Article
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.874385
- By:
- Publication type:
- Article
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer.
- Published in:
- Technology in Cancer Research & Treatment, 2021, p. 1, doi. 10.1177/15330338211062324
- By:
- Publication type:
- Article
Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221117638
- By:
- Publication type:
- Article